cov    pid  1 [        .         .         .         .         :         .         .         . 80 
 1 CSKP_MOUSEb    100.0% 100.0%    AVQRAKEVLEEISCYPEN-------NDAKELKRILTQ------------------------PHFMALLQTHDVVAHEVYS    
 2 p55Tb          100.0%  32.7%    NLELVNEILEDITPLISVD------ENVAELVGILKE------------------------PHFQSLLEAHDIVASKCYD    
 3 CMG_DROMEb     100.0%  45.0%    AVGRCRDVLEQLSSTSGGNSLGGK-YAKEELMRLLAA------------------------PHMQALLHSHDVVARDVYG    
 4 MPP3_HUMANb    100.0%  33.3%    AVALAEDVMEELQAASVH-------SDERELLQLLST------------------------PHLRAVLMVHDTVAQKNFD    
 5 MPP2_HUMANb    100.0%  34.5%    NLELVQEILRDLAQLAEQS------STAAELAHILQE------------------------PHFQSLLETHDSVASKTYE    
 6 LIN2_CAEEL     100.0%  27.3%    TSTLRKETLNQIDGLLGPS------PEALELRQLLNS------------------------PHLASCVQALDVVVCEIRD    
 7 PALS1b          98.1%  27.8%    VQDLVQEVQTVLKPVHQ--------KEGQELTALLNA------------------------PHIQALLLAHDKVAEQEMQ    
 8 HSZZ27178      100.0%  31.5%    AAALADDLAEELQNKPLN-------SEIRELLKLLSK------------------------PNVKALLSVHDTXAQKNYD    
 9 CSKP_MOUSEa    100.0%  21.4%    AVSQVLDSLEEIHALTDCSE-----KDLDFLHSVFQD------------------------QHLHTLLDLYDKINTKSSP    
10 p55Ta           98.1%  20.0%    -MQQVLENLTELPSSTGAEE-----IDLIFLKGIMEN------------------------PIVKSLAKAHERLEDSKLE    
11 CMG_DROMEa     100.0%  27.3%    AVQRILDCLDDIYSLQDAH------VDADVLRDMLRD------------------------NRLHQFLQLFDRIAATVVT    
12 MPP3_HUMANa    100.0%   5.5%    LHETLALLTSQLRPDSNHK------EEMGFLRDDFSE------------------------KSLSYLMKIHEKLRYYERQ    
13 MPP2_HUMANa    100.0%   8.8%    AMQQVLDNLGSLPSATGAAE-----LDLIFLRGIMESPIVRSLAKVIMVLWFMQQNVFVPMKYMLKYFGAHERLEETKLE    
14 LIN2_CAEELa    100.0%   9.1%    KVLGSLDAINSLLDPNSYK------PGSTTFQKIHDD------------------------GSVRNLLRLYDKIKALPCE    
15 PALS1a         100.0%  13.8%    DVEDLFSSLKHIQHTLVDSQSQ---EDISLLLQLVQN------------------------RDFQNAFKIHNAVTVHMSK    
16 LIN-7          100.0%  21.4%    DVQRILELMEHVQKTGEVNN-----AKLASLQQVLQS------------------------EFFGAVREVYETVYESIDA    
17 LIN-7-BA       100.0%  19.6%    DVARAIELLEKLQESGEVPV-----HKLQSLKKVLQS------------------------EFCTAIREVYQYMHETITV    
18 hypLIN7         75.9%  16.3%    -------------RCPEIQP-----SKLAALQRILQS------------------------DFCDMIREVYEHIYTTVDI    
19 DLG1_HUMAN     100.0%  16.4%    DTQRALHLLEEYRSKLSQTEDR---QLRSSIERVINI---------------------FQSNLFQALIDIQEFYEVTLLD    
20 O88910         100.0%  31.5%    AMALAEDVMEELQAASVH-------SDERELLQLLST------------------------PHLRAVLMVHDTVAQKNFD    
21 Q9NUP9         100.0%  21.4%    DICRAIELLEKLQRSGEVPP-----QKLQALQRVLQS------------------------EFCNAVREVYEHVYETVDI    
22 Q9W7F1a        100.0%  33.3%    AGSLAADLTEELQARSAS-------NEIRELVKLLSK------------------------PHVKSLLSVHDTVAKKSYD    
23 Q9D2Q1         100.0%  19.6%    DVSRAVELLERLQRSGELPP-----QKLQALQRVLQS------------------------RFCSAIREVYEQLYDTLDI    
24 Q96JB8a        100.0%  31.5%    AQVLSYEVVELLRETPTS-------PEIQELRQMLQA------------------------PHFKALLSAHDTIAQKDFE    
25 CE03223        100.0%   9.1%    KVLGSLDAINSLLDPNSYK------PGSTTFQKIHDD------------------------GSVRNLLRLYDKIKALPCE    
26 Q95TF5         100.0%  18.0%    KAHRALELLEDYHARLSEPQDR---ALRIAIERVIRI---------------------FKSRLFQALLDIQEFYELTLLD    
27 Q9D3K2         100.0%   7.3%    LYELLAALPAQLQPHVDSQ------EDLTFLWDVFGE------------------------KSLHSLVKIHEKLHCYEKQ    
28 Q9W7F1         100.0%   8.5%    SEMGLYELLSVLPSQLQPH------VESPDDRSFLHA--------------------MFGERSLHSLVKIHEKLQCYEDC    
29 Q96M62         100.0%  11.9%    SDTGLYELLAALPAQLQPH------VDSQEDLTFLWD--------------------MFGEKSLHSLVKIHEKLHYYEKQ    
30 T15617         100.0%  18.0%    KAHKAIENVEDYCQTLTRH--GNE-ELRTNLERVITT---------------------FKSNLMHSLLDIHDLYEQTLLS    
31 Q9V5U1a        100.0%  22.2%    ALSKLISTLKESENLSND-------QEIDFLKALLES------------------------KELNALVNVHTKVAKVGRD    
32 Q9V5U1b        100.0%  29.1%    SAQVLYEVLEQLSQHCHLN------DDCKEAFHLLQD------------------------SHLQHLLFAHDAIAQKDFY    
33 Q96JB8         100.0%  23.2%    LSQILRLVLQELSLFYSRDV-----NGVCLLYDLLHS------------------------PWLQALLKIYDCLQEFKEK    
34 AAF81829       100.0%  14.8%    ALQQIEAVKKGIDESDDPKLQMQTAESLSTILGILQD------------------------PVFRTIVHVQDSLSELNAQ    
35 AAM28433       100.0%   9.8%    DKLQVLQVLDRLKMKLQEKGDTSQNEKLSMFYETLKS------------------------PLFNQILTLQQSIKQLKGQ    
   consensus/100%                  ................................t.h............................h..hh...p........    
   consensus/90%                   ......t.ht.h..............t...h.thhpt..........................htthh.h.p.h......    
   consensus/80%                   ththh.phhppl.t..t.........pht.l.pllpp..........................hpslhpha-hltth..t    
   consensus/70%                   shthhh-hlpplpth.p........tchptLhpllps.........................hhpsllpla-pltpp.hp    

                     cov    pid 81     ] 85 
 1 CSKP_MOUSEb    100.0% 100.0%    DEALR    
 2 p55Tb          100.0%  32.7%    SPPSS    
 3 CMG_DROMEb     100.0%  45.0%    EEALR    
 4 MPP3_HUMANb    100.0%  33.3%    PVLPP    
 5 MPP2_HUMANb    100.0%  34.5%    TPPPS    
 6 LIN2_CAEEL     100.0%  27.3%    PKNEA    
 7 PALS1b          98.1%  27.8%    LEPIT    
 8 HSZZ27178      100.0%  31.5%    PVLPP    
 9 CSKP_MOUSEa    100.0%  21.4%    QIRNP    
10 p55Ta           98.1%  20.0%    AVSDN    
11 CMG_DROMEa     100.0%  27.3%    SNGRA    
12 MPP3_HUMANa    100.0%   5.5%    SPTPV    
13 MPP2_HUMANa    100.0%   8.8%    AVRDN    
14 LIN2_CAEELa    100.0%   9.1%    PVVTE    
15 PALS1a         100.0%  13.8%    ASPPF    
16 LIN-7          100.0%  21.4%    DTTPE    
17 LIN-7-BA       100.0%  19.6%    NGCPE    
18 hypLIN7         75.9%  16.3%    NGSEE    
19 DLG1_HUMAN     100.0%  16.4%    NPKCI    
20 O88910         100.0%  31.5%    PVLPP    
21 Q9NUP9         100.0%  21.4%    SSSPE    
22 Q9W7F1a        100.0%  33.3%    PELPP    
23 Q9D2Q1         100.0%  19.6%    TGSAE    
24 Q96JB8a        100.0%  31.5%    PLLPP    
25 CE03223        100.0%   9.1%    PVVTE    
26 Q95TF5         100.0%  18.0%    DSKSI    
27 Q9D3K2         100.0%   7.3%    NPLPI    
28 Q9W7F1         100.0%   8.5%    APTPV    
29 Q96M62         100.0%  11.9%    GPVPI    
30 T15617         100.0%  18.0%    ERKSD    
31 Q9V5U1a        100.0%  22.2%    DRLAP    
32 Q9V5U1b        100.0%  29.1%    PHLPE    
33 Q96JB8         100.0%  23.2%    KLVPA    
34 AAF81829       100.0%  14.8%    LAQHP    
35 AAM28433       100.0%   9.8%    LNHIP    
   consensus/100%                  .....    
   consensus/90%                   .....    
   consensus/80%                   s....    
   consensus/70%                   s.hs.